Molecular forms of butyrylcholinesterase and obesity
Boberg, Dellyana R; Furtado-Alle, Lupe; Souza, Ricardo L. R; Chautard-Freire-Maia, Eleidi A.
Genet. mol. biol
; 33(3): 452-454, 2010. tab
Artículo en Inglés | LILACS | ID: lil-555834
Documentos relacionados
Plasma butyrylcholinesterase activity: a possible biomarker for differential diagnosis between Alzheimer's disease and dementia with Lewy bodies?
A Case Report of Primary Neonatal Hypocholinesterase Caused by Homozygous Frameshift Mutation of the utyrylcholinesterase (BCHE) Gene and Review of Literature.
The impact of sialylation linkage-type on the pharmacokinetics of recombinant butyrylcholinesterases.
The C5 Variant of the Butyrylcholinesterase Tetramer Includes a Noncovalently Bound 60 kDa Lamellipodin Fragment.
Genetic Association of Butyrylcholinesterase with Major Depressive Disorder.
Biochemical Analysis and Association of Butyrylcholinesterase SNPs rs3495 and rs1803274 with Substance Abuse Disorder.
Adenovirus-mediated gene transfer of human butyrylcholinesterase results in persistent high-level transgene expression in vivo.
Dysregulation of butyrylcholinesterase, BCHE gene SNP rs1803274, and pro-inflammatory cytokines in occupational workers.
Gene-delivered butyrylcholinesterase is prophylactic against the toxicity of chemical warfare nerve agents and organophosphorus compounds.
Whole body and tissue imaging of the butyrylcholinesterase knockout mouse injected with near infrared dye labeled butyrylcholinesterase.